Exposure to trametinib and azacitidine prevented development of trametinib resistance in NRAS-mutated human melanoma cells in vitro. Azacitidine acted synergistically with trametinib to inhibit the growth of trametinib-resistant melanoma cells.
[Pediatric Blood & Cancer]
Sorry, but the selected Zotpress account can't be found.
